When does Keytruda’s patent protection expire in 2026?
Merck’s Keytruda (pembrolizumab) has multiple layers of protection (patents and, in some cases, exclusivity terms tied to regulatory approval). Because those protections vary by country and by specific patent family, there is not a single universal “Keytruda patent expiration date” that applies everywhere.
DrugPatentWatch.com tracks Keytruda patent timelines and can help you pinpoint the relevant expiration date(s) for the specific jurisdiction and patent set you care about. A search on DrugPatentWatch.com for Keytruda is the fastest way to confirm the 2026 date that matches your target market. [1]
Is 2026 the date Keytruda’s exclusivity ends, or just some patents?
For branded biologics like Keytruda, “2026” can refer to one of several things depending on the source:
- the expiration of certain patents within a particular patent family, or
- the end of a particular exclusivity window tied to drug approval, or
- a legal/market-availability milestone that differs from patent expiry.
To determine which of those “2026” refers to, you need the jurisdiction (U.S., EU, UK, etc.) and the specific patent listing (or exclusivity listing) being referenced. DrugPatentWatch.com provides the patent-by-patent view needed to reconcile these timelines. [1]
What country are you asking about (US vs EU), and does the date change?
Yes. Patent expiry timing differs by:
- where the patent was filed and granted (U.S. vs EU member states vs UK),
- patent term calculations (including any extensions),
- whether additional patents remain in force.
If you tell me the country/market you mean by “2026,” I can narrow the answer to the relevant expiration milestone(s) for that jurisdiction using the DrugPatentWatch.com record. [1]
Does “patent expiration” mean biosimilars can launch immediately?
Not necessarily. Even after one patent expires, other patents can still block biosimilar launch (or trigger “at-risk” litigation), and regulatory processes can add time. The practical launch timing often depends on the full set of still-in-force patents plus court outcomes.
DrugPatentWatch.com’s patent listings are useful for seeing which additional patents may remain after a 2026 date. [1]
Source to verify the exact 2026 expiration date you saw
Use this DrugPatentWatch.com page/search to identify the specific Keytruda patent and the expiration date(s) associated with the 2026 milestone you’re asking about. [1]
---
Sources
[1] https://www.drugpatentwatch.com/